The Division of Radiation Health is a division under Department of Pharmaceutical Sciences, College of Pharmacy.
The focus of the Division of Radiation Health is to study the interactions between ionizing radiation and various normal tissues of the human body and to develop pharmaceutical interventions that can prevent the adverse effects of radiation in normal tissues.
The significance of this research relates both to efforts directed at improving the quality of life of long term cancer survivors and to the development of medical countermeasures against radiological and nuclear threats.
The overall goal of our work is to make radiation therapy more tolerable, more effective, and safer, and to provide highly effective, non-toxic pharmaceutical countermeasures against radiological and nuclear threats.
Research performed by the faculty of the Division of Radiation Health will eventually help improve cancer cure rates, reduce the side effects of cancer therapy, and enhance the quality of life of cancer survivors. It will also contribute to improving the outcome in the event of a radiological or nuclear incident.